2 ms·
Agreed, but acquisitions of public companies typically get regulatory attention up-front. An insurer buying 23andme would be an obvious red flag from day one.
by kube-system 3y ago
Agreed, but acquisitions of public companies typically get regulatory attention up-front. An insurer buying 23andme would be an obvious red flag from day one.